News
Atavistik Bio has raised US$160m to develop new treatments for rare blood disorders and cancers using a drug design approach aimed at previously hard-to-target proteins. Atavistik Bio develops oral medicines designed to bind to what are known as allosteric sites on proteins. Proteins are molecules in the body that control many biological processes. Most small-molecule [...]
McDermott Will & Schulte has advised Maire Group on the conclusion and implementation of its joint venture agreements with Newcleo SA. Maire, through its subsidiary Nextchem, and Newcleo SA, an innovative company in the nuclear energy sector co‑founded by Stefano Buono, have completed the establishment of NEXT‑N, a joint venture focused on developing advanced technologies [...]
Oura has acquired Doublepoint, a startup specialising in gesture recognition technology for wearable devices. Oura announced the acquisition on Thursday, saying the technology allows users to control wearables through simple hand movements using artificial intelligence and biometric data. Financial terms were not disclosed. The move opens the possibility of adding gesture-based controls to Oura’s smart [...]
Minnesota Medical Technologies has raised US$20.6m to launch its StaySure device for fecal incontinence in the US, offering an alternative to absorbent products. The company, founded in 2015, developed StaySure in collaboration with Mayo Clinic gastroenterologist Adil Bharucha. The single-use device is intended as an alternative to absorbent products such as adult nappies and pads, [...]
Magentus, a leading name in clinical diagnostics, announces the formation of a UK Advisory Board to guide the next phase of its strategy and reaffirm its long-term commitment to the UK health system. The announcement marks a significant milestone in Magentus’ renewed leadership in the UK market. It reinforces the company’s focus on earlier diagnosis, [...]
McDermott Will & Schulte has advised Groupe Bruxelles Lambert (“GBL”) in connection with its strategic investment in Rayner, a leading ophthalmic MedTech specialist. GBL has signed definitive agreements to acquire a 45% co‑control stake in Rayner. Under the transaction, GBL will invest €0.5 billion of equity alongside incumbent shareholders, including CVC and the Rayner management [...]
New research from Appian (Nasdaq: APPN) shows the NHS is the most trusted organisation for responsible AI use, ranking higher than any other public or private sector organisation, including banks, retailers, and consumer tech firms. The 2026 UK Public Sector AI Adoption Outlook, conducted by Censuswide on behalf of Appian, polled 1,000 UK public sector workers and [...]
VitalHub UK and CEMBooks have announced a partnership focused on supporting NHS organisations with complementary digital tools for operational insight and situational awareness. The partnership brings together SHREWD, VitalHub UK’s system-level operational platform used to support escalation, coordination, reporting and digital OPEL, with CEMBooks’ department-focused operational management tools. The aligned solutions uniquely enable organisations to [...]
Electiva Healthcare Group has unveiled a new Patient Charter and strengthened clinical governance framework in a significant move to raise safety, transparency and accountability standards across its expanding UK network. The announcement comes amid growing national focus on clinical governance, as healthcare providers face increasing scrutiny to ensure patient safety and quality keep pace with [...]
A new showcase series is reshaping NHS-supplier engagement. Pioneers at the first NHS host brought together hundreds of staff organisation-wide, along with major tech companies and niche innovators in a single day, already inspiring 10 further NHS providers to follow in 2026. Highland has launched Elevate, a new health tech event series that is bringing [...]
